Search
forResearch 10 of 1000+
- 170 Forecasting Phase 3 Dose-Response for Abrocitinib, an Oral Janus Kinase 1 Selective Inhibitor, Using Investigator’s Global Assessment and Eczema Area and Severity Index
- The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
- 396 A novel investigator global assessment score for the evaluation of keratosis pilaris
- Genomic and phenotypic characterization of Investigator Global Assessment (IGA) scale-based endotypes in atopic dermatitis
- 44180 Influence of Baseline Disease Severity Defined by Investigator’s Global Assessment on Abrocitinib Efficacy for up to 96 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis: Interim Analysis of JADE EXTEND, a Long-Term Extension Study
- 76221 Faster Onset and Superior Efficacy of an Investigational Extended-Release Oral Minoxidil Tablet (VDPHL01) Versus Topical and Immediate-Release Oral Minoxidil for Androgenetic Alopecia: Results from a Blinded Retrospective Investigator Global Assessment
- Reproducibility of global photographic assessments of patients with male pattern baldness in a clinical trial with finasteride.
- Adherence to topical hydrocortisone 17-butyrate 0.1% in different vehicles in adults with atopic dermatitis
- 490 Samcyprone (diphenylcyclopropenone ointment) for the treatment of common warts
- Dupilumab for the treatment of alopecia areata in pediatric patients with atopic dermatitis: A scoping review
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →